US EditionPublished • loading... • Updated
Cyclerion Provides Public Listing Vehicle for Korsana in $380M Deal
The combined company will trade as Korsana Biosciences and use the financing to fund operations into 2029, with Alzheimer’s data expected in 2027.
Summary by Hastings Tribune
8 Articles
8 Articles
Hastings Tribune+4 Reposted by 4 other sources
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement
WALTHAM, Mass.--(BUSINESS WIRE)--Apr 1, 2026-
·Nebraska, United States
Read Full Article
Paragon offshoot Korsana to go public in reverse merger for Alzheimer's work
Jonathan Violin loves a reverse merger, and so does Paragon Therapeutics. Violin is taking Korsana Biosciences' fight against Alzheimer's public. Korsana will gain access to more capital as it rides the tailwinds of Roche's similar ...
Coverage Details
Total News Sources8
Leaning Left0Leaning Right0Center4Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
